STOCK TITAN

[Form 4] PERRIGO COMPANY PLC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4

Abigail Lennox, EVP and CSO of Perrigo Company plc, reported acquiring 1,255 ordinary shares on 09/08/2025 at $22.41 per share, leaving her beneficial ownership at 1,255 shares. The Form 4 was signed by an attorney-in-fact and shows the transaction was a direct purchase.

Abigail Lennox, EVP e CSO di Perrigo Company plc, ha riportato di aver acquisito 1.255 azioni ordinarie il 09/08/2025 a 22,41$ ciascuna, portando la sua partecipazione beneficiaria a 1.255 azioni. Il Modulo 4 è stato firmato da un procuratore e indica che la transazione è stata un acquisto diretto.

Abigail Lennox, EVP y CSO de Perrigo Company plc, informó la adquisición de 1.255 acciones ordinarias el 09/08/2025 a $22.41 por acción, dejando su propiedad beneficiaria en 1.255 acciones. El Formulario 4 fue firmado por un apoderado y muestra que la transacción fue una compra directa.

퍼리고 컴퍼니 plc의 EVP 겸 CSO인 Abigail Lennox는 2025/08/09에 보통주 1,255주를 주당 $22.41에 취득했다고 보고했으며, 그녀의 실소유 주식 수는 1,255주로 남았습니다. Form 4는 대리인이 서명했으며 거래는 직접 매수로 표시되어 있습니다.

Abigail Lennox, EVP et CSO de Perrigo Company plc, a déclaré l'acquisition de 1 255 actions ordinaires le 09/08/2025 au prix de 22,41 $ par action, portant sa détention bénéficiaire à 1 255 actions. Le formulaire 4 a été signé par un mandataire et indique qu'il s'agissait d'un achat direct.

Abigail Lennox, EVP und CSO von Perrigo Company plc, meldete den Erwerb von 1.255 Stammaktien am 09.08.2025 zu je 22,41 $, womit ihr wirtschaftliches Eigentum bei 1.255 Aktien liegt. Das Formular 4 wurde von einem Bevollmächtigten unterschrieben und weist die Transaktion als direkten Kauf aus.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: A routine, small-scale insider purchase was timely reported; no governance red flags.

The filing documents a direct purchase by an executive officer, which is a standard disclosure under Section 16. The transaction size (1,255 shares) and price ($22.41) are modest relative to typical company market caps and do not indicate any unusual trading pattern or apparent conflict. The form is signed by an attorney-in-fact, consistent with authorized proxy signing practices.

TL;DR: Minor insider buy noted; unlikely to be material to valuation but maintains transparency.

The acquisition is recorded as a direct purchase (code P) for 1,255 ordinary shares at $22.41 each. Given the small absolute size, this transaction is unlikely to move market perceptions or materially affect share count. It does, however, fulfill reporting obligations and preserves regulatory transparency.

Abigail Lennox, EVP e CSO di Perrigo Company plc, ha riportato di aver acquisito 1.255 azioni ordinarie il 09/08/2025 a 22,41$ ciascuna, portando la sua partecipazione beneficiaria a 1.255 azioni. Il Modulo 4 è stato firmato da un procuratore e indica che la transazione è stata un acquisto diretto.

Abigail Lennox, EVP y CSO de Perrigo Company plc, informó la adquisición de 1.255 acciones ordinarias el 09/08/2025 a $22.41 por acción, dejando su propiedad beneficiaria en 1.255 acciones. El Formulario 4 fue firmado por un apoderado y muestra que la transacción fue una compra directa.

퍼리고 컴퍼니 plc의 EVP 겸 CSO인 Abigail Lennox는 2025/08/09에 보통주 1,255주를 주당 $22.41에 취득했다고 보고했으며, 그녀의 실소유 주식 수는 1,255주로 남았습니다. Form 4는 대리인이 서명했으며 거래는 직접 매수로 표시되어 있습니다.

Abigail Lennox, EVP et CSO de Perrigo Company plc, a déclaré l'acquisition de 1 255 actions ordinaires le 09/08/2025 au prix de 22,41 $ par action, portant sa détention bénéficiaire à 1 255 actions. Le formulaire 4 a été signé par un mandataire et indique qu'il s'agissait d'un achat direct.

Abigail Lennox, EVP und CSO von Perrigo Company plc, meldete den Erwerb von 1.255 Stammaktien am 09.08.2025 zu je 22,41 $, womit ihr wirtschaftliches Eigentum bei 1.255 Aktien liegt. Das Formular 4 wurde von einem Bevollmächtigten unterschrieben und weist die Transaktion als direkten Kauf aus.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lennox Abigail

(Last) (First) (Middle)
C/O PERRIGO COMPANY PLC
515 EASTERN AVENUE

(Street)
ALLEGAN MI 49010

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PERRIGO Co plc [ PRGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and CSO
3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 09/08/2025 P 1,255 A $22.41 1,255 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Diana Witt, attorney-in- fact for Ms. Abigail Lennox 09/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Perrigo Co Plc

NYSE:PRGO

PRGO Rankings

PRGO Latest News

PRGO Latest SEC Filings

PRGO Stock Data

3.04B
136.97M
0.41%
105.88%
5.38%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2